Drug Shortage Report for TEVA-ROSUVASTATIN
| Report ID | 120250 |
| Drug Identification Number | 02354624 |
| Brand name | TEVA-ROSUVASTATIN |
| Common or Proper name | ROSUVASTATIN 20MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ROSUVASTATIN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2020-07-13 |
| Estimated end date | Unknown |
| Actual end date | 2023-04-27 |
| Shortage status | Resolved |
| Updated date | 2023-04-28 |
| Company comments | Allocating 100% of Teva market for duration of risk period. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v24 | 2023-04-28 | English | Compare |
| v23 | 2023-04-27 | French | Compare |
| v22 | 2023-04-27 | English | Compare |
| v21 | 2021-05-06 | French | Compare |
| v20 | 2021-05-06 | English | Compare |
| v19 | 2021-04-01 | French | Compare |
| v18 | 2021-04-01 | English | Compare |
| v17 | 2021-03-25 | French | Compare |
| v16 | 2021-03-25 | English | Compare |
| v15 | 2021-03-04 | French | Compare |
| v14 | 2021-03-04 | English | Compare |
| v13 | 2021-01-14 | French | Compare |
| v12 | 2021-01-14 | English | Compare |
| v11 | 2021-01-07 | French | Compare |
| v10 | 2021-01-07 | English | Compare |
| v9 | 2020-09-22 | French | Compare |
| v8 | 2020-09-22 | English | Compare |
| v7 | 2020-08-20 | French | Compare |
| v5 | 2020-08-20 | English | Compare |
| v6 | 2020-08-20 | English | Compare |